The author discusses the quality of life of children treated for sickle cell disease in high-income countries. He mentions the risk of brain injury and academic performance of the children, blood transfusions preventing overt strokes, and issues like organ failure. Routine health checkups and decreasing associated diseases after treatment are mentioned.